series-c-plus
Stage
1
Investors
About
Reneo is a clinical stage pharmaceutical company focused on developing therapies for patients with genetic mitochondrial diseases.
Explore Reneo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.